COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2

COVID 补充：一项多中心研究，旨在研究感染 SARS-CoV-2 后产生的免疫反应

• 批准号: 10621133
• 负责人: TED ROSS
• 金额: $ 6.11万
• 依托单位: UNIVERSITY OF GEORGIA
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-10 至 2023-05-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10621133
• 关键词: 2019-nCoV; Affect; Antibody Response; Antibody titer measurement; Antibody-mediated protection; COVID-19 survivors; Employee; Foundations; Frontline worker; Goals; Health; Immune response; Infection; Minority; National Cancer Institute; Research; Site; Universities; Virus; coronavirus disease; first responder; high risk population

The Georgia University Research Foundation to support the National Cancer Institute's multi-site study seeking to evaluate antibody responses to SARS-CoV-2 virus in high risk populations including health workers, first responders, frontline worker (e.g. grocery store employees) and disproportionately affected minorities. The goal of the study is to determine the durability of antibody titers following COVID infection and to identify correlates of antibody-mediated protection from re-infection in COVID survivors.

格鲁吉亚大学研究基金会支持国家癌症研究所的多地点研究，旨在评估高危人群对SARS-CoV-2病毒的抗体反应，包括卫生工作者，第一反应者，一线工作人员（例如杂货店员工）和受影响不成比例的少数群体。 该研究的目的是确定COVID感染后抗体滴度的持久性，并确定COVID幸存者中抗体介导的保护免受再次感染的相关性。